Trade Winds Turning: 3 Stocks Poised to Gain from Biden’s China Tariffs

  • As Biden’s tariffs hit Chinese imports, savvy investors are eyeing solar energy and healthcare equipment stocks to gain a competitive edge.
  • First Solar (FSLR): It stands to capture market share with a low P/E ratio and an EPS increase, with analysts predicting over 15% price growth.
  • Embecta (EMBC): Trading at a P/E of 11.4x with strong EPS and insider buying, it indicates executive confidence despite a YTD price dip.
  • Top Glove (TGLVY): Set to benefit as U.S. buyers diversify suppliers away from China, with a potential 94% revenue jump offering a rebound.
stocks to benefit from China tariffs - Trade Winds Turning: 3 Stocks Poised to Gain from Biden’s China Tariffs

Source: humphery /

The White House recently confirmed increased tariffs on various Chinese goods. Investors and traders are on the lookout for stocks to benefit from China tariffs as the change could significantly impact many industries, including the U.S. automotive industry, electric vehicles (EVs) and others. Tariffs were, in fact, applied to several important products such as solar cells, cranes, steel, aluminum and batteries.

Finding stocks to benefit from China tariffs is not an easy task amid these changes. Tariffs may impact overall market conditions and even affect the timing of the Fed’s interest rate cut. Therefore, subsequent market fluctuations likely create risks and opportunities for investors, making picking the right sectors critical.

As companies face higher import costs, particular sectors and stocks will undoubtedly perform well while others may struggle. Given the broad scope of industries involved, several names are poised to benefit from the latest China tariffs beyond just EV manufacturers receiving media attention.

The market has already begun to react to Biden’s China tariffs, so traders may need to consider additional areas to find stocks well-positioned to benefit from trade winds turning. Three picks are:

First Solar (FSLR)

Person holding smartphone with logo of US renewable energy company First Solar Inc. (FSLR) on screen in front of website. Focus on phone display. Unmodified photo.
Source: T. Schneider /

First Solar (NASDAQ:FSLR) could be among the major stocks to benefit from China tariffs. As a domestic producer of solar panels, First Solar manufactures and provides utility-scale photovoltaic (PV) power plants. Its cadmium telluride panels reduce carbon emissions compared to conventional crystalline silicon panels. This places the company to gain market share from Biden’s solar tariffs on China as well as seize opportunities from companies seeking to minimize their carbon footprint. The White House’s focus on combating climate change further supports company growth. Furthermore, the tariffs will apply to solar panels and cells imported from Cambodia, Malaysia, Thailand and Vietnam, which currently dominate U.S. solar imports.

Despite nearly doubling its EPS from $0.12 per share to $0.21 per share in the first quarter compared to the prior quarter, First Solar maintains a modest price-to-earnings (P/E) ratio of 20.7x for a technology company. While FSLR stock has risen substantially in recent months, analysts see continued upside, with an average price target over 15% above the current level of $228.27 per share.

Embecta (EMBC)

A syringe with a safety cap and a surgical mask laid out on a blank background
Source: Ursi

Another area targeted by recent U.S. tariffs is healthcare equipment, including syringes and face masks. One of the large manufacturers in this industry is Becton Dickinson (NYSE:BDX). However, its recently spun-off dialysis spin-off Embecta (NASDAQ:EMBC) presents one of the better stocks to benefit from China tariffs. Its smaller size and better valuation ratios make it potentially more attractive than its former parent company.

The Embecta stock price has declined year-to-date (YTD), but the EMBC share price received a minor boost following the tariff announcement. This followed an initial 38% boost earlier in May on the back of the company’s earnings release. Quarterly EPS doubled from $0.24 to $0.50 and profit margins rose 10% on revenue of $287.2 million.

Insider purchasing activity signals that company executives have confidence in the firm. They have been acquiring additional shares at an average price of $19.59 per share, 40% above the current EMCB share price. Embecta trades at a P/E ratio of 11.4x, less than half the healthcare industry average of 25.9x.

Top Glove (TGLVY)

Source: ©

Top Glove (OTCMKTS:TGLVY), a Malaysian manufacturer of disposable gloves, is another one of the stocks to benefit from China tariffs. Among the tariffs, the U.S. decided to impose up to 50% on certain personal protective equipment imports, including latex and nitrile gloves. As a result, U.S. healthcare providers, law enforcement agencies, and food companies will likely seek alternative suppliers outside of China. Top Glove, which experienced significant demand during the Covid-19 pandemic, is well-positioned to capture additional orders from the U.S. market.

The Top Glove stock price has declined since it reported dismal earnings for the fourth quarter. However, analysts may upgrade their ratings in light of potential new business opportunities resulting from the tariffs. Estimates show a 15% annual revenue growth rate, higher than the industry average. In fact, analyst coverage suggests revenues are expected to increase as much as 94% in 2024. This could help boost the TGLVY share price going forward.

On the date of publication, Stavros Tousios did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the Publishing Guidelines.

Stavros Tousios, MBA, is the founder and chief analyst at Markets Untold. With expertise in FX, macros, equity analysis, and investment advisory, Stavros delivers investors strategic guidance and valuable insights.

Article printed from InvestorPlace Media,

©2024 InvestorPlace Media, LLC